RR
Ranga Rao Bopparaju
About Ranga Rao Bopparaju
Data last updated:
Ranga Rao Bopparaju is a Director at Shreetanu Pharma Chem India Private Limited (since 2010) and Director at Sark Bio-Sciences Private Limited (since 2022). The companies operate in Chemicals and Healthcare. The largest current company by reported revenue is Shreetanu Pharma Chem India Private Limited at ₹8.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Nov 2010 | 2010 | ₹8.1 Lakh (FY 2025) | Active | |
| Director | 27 Jun 2022 | 2022 | Active |
Board colleagues of Ranga Rao Bopparaju
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepika Bopparaju | 03207672 | Shreetanu Pharma Chem India Private Limited | Director |
| Allada Sirisha | 09653698 | Sark Bio-Sciences Private Limited | Director |
| Mohammed Asgar Hussen | 09653697 | Sark Bio-Sciences Private Limited | Director |
| Vamshi Krishna Modem | 09653696 | Sark Bio-Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ranga Rao Bopparaju
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ranga Rao Bopparaju
Ranga Rao Bopparaju currently holds 2 directorships: Shreetanu Pharma Chem India Private Limited (Director, since 20 Nov 2010, revenue ₹8.1 Lakh (FY 2025)); Sark Bio-Sciences Private Limited (Director, since 27 Jun 2022).
Ranga Rao Bopparaju was first appointed on 20 Nov 2010 as Director at Shreetanu Pharma Chem India Private Limited. The most recent appointment on record is 27 Jun 2022 at Sark Bio-Sciences Private Limited.
The current boards of Ranga Rao Bopparaju's companies include Deepika Bopparaju (Shreetanu Pharma Chem India Private Limited), Allada Sirisha (Sark Bio-Sciences Private Limited), Mohammed Asgar Hussen (Sark Bio-Sciences Private Limited), Vamshi Krishna Modem (Sark Bio-Sciences Private Limited).